Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new G enzyme. Its products includes prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines and other medical products.The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to 1970. In December 1999, Rhône-Poulenc and Hoechst Marion Roussel formalized their merger with the creation of the Franco-German group Aventis, one of the world's largest pharmaceutical companies. In August 2004, Sanofi-Synthelabo acquired Aventis. The takeover was finalized on December 31 of that year, giving birth to sanofi-aventis.On May 6, 2011, sanofi-aventis simplified its name to Sanofi. Sanofi  operates in over 100 countries throughout the world.
Publicly Held
Corporate Backed or Acquired
“At Sanofi, we strive to develop healthcare solutions with patients, not just for patients.” Victoria DiBiaso, Global Head, Patient Informed Development & Health Value Translation, shares how putting patients first is making a difference in #RD & beyond: https://t.co/O3dqExvEpm
Drawing on a global ecosystem and millions of powerful voices, we will successfully make a difference for people living with #rarediseases. https://t.co/JkInOI2Brx #Pledge4Rare
“At Sanofi, we strive to develop healthcare solutions with patients, not just for patients.” Victoria DiBiaso, Global Head, Patient Informed Development & Health Value Translation, shares how putting patients first is making a difference in #RD & beyond: https://t.co/O3dqExvEpm
Drawing on a global ecosystem and millions of powerful voices, we will successfully make a difference for people living with #rarediseases. https://t.co/JkInOI2Brx #Pledge4Rare
There is an increasingly greater need for continued scientific investigation and collaboration worldwide. Hear why oncologist Dr. Ahmet Sezer believes more research can help us better refine and understand treatment options for patients with advanced #NSCLC. https://t.co/xcW2WDiKpD
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.
Add a review